Counterpoint: pharmacogenetic-based initial dosing of warfarin: not ready for prime time.

Research output: Contribution to journal › Comment/debate

Access to Document

@article{b04284b3e88f4fbea535b6a8cb292ee5,

title = "Counterpoint: pharmacogenetic-based initial dosing of warfarin: not ready for prime time.",

author = "Eby, \{Charles S.\}",

year = "2009",

month = apr,

doi = "10.1373/clinchem.2008.115972",

language = "English",

volume = "55",

pages = "712--714",

journal = "Clinical chemistry",

issn = "0009-9147",

number = "4",

}

TY - JOUR

T1 - Counterpoint

T2 - pharmacogenetic-based initial dosing of warfarin: not ready for prime time.

AU - Eby, Charles S.

PY - 2009/4

Y1 - 2009/4

UR - https://www.scopus.com/pages/publications/64149087950

U2 - 10.1373/clinchem.2008.115972

DO - 10.1373/clinchem.2008.115972

M3 - Comment/debate

C2 - 19233915

AN - SCOPUS:64149087950

SN - 0009-9147

VL - 55

SP - 712

EP - 714

JO - Clinical chemistry

JF - Clinical chemistry

IS - 4

ER -